Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.
American Cancer Society
Breast Neoplasms
/ epidemiology
Centers for Disease Control and Prevention, U.S.
Colorectal Neoplasms
/ epidemiology
Early Detection of Cancer
Female
Healthy People Programs
Humans
Lung Neoplasms
/ epidemiology
Male
Mortality
National Cancer Institute (U.S.)
Prostatic Neoplasms
/ epidemiology
Registries
Risk Factors
United States
/ epidemiology
Healthy People 2020
cancer
epidemiology
surveillance
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 05 2020
15 05 2020
Historique:
received:
16
12
2019
revised:
17
01
2020
accepted:
31
01
2020
pubmed:
13
3
2020
medline:
15
1
2021
entrez:
13
3
2020
Statut:
ppublish
Résumé
The Centers for Disease Control and Prevention, the American Cancer Society, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States and to address a special topic of interest. Part I of this report focuses on national cancer statistics, and part 2 characterizes progress in achieving select Healthy People 2020 cancer objectives. For this report, the authors selected objectives-including death rates, cancer screening, and major risk factors-related to 4 common cancers (lung, colorectal, female breast, and prostate). Baseline values, recent values, and the percentage change from baseline to recent values were examined overall and by select sociodemographic characteristics. Data from national surveillance systems were obtained from the Healthy People 2020 website. Targets for death rates were met overall and in most sociodemographic groups, but not among males, blacks, or individuals in rural areas, although these groups did experience larger decreases in rates compared with other groups. During 2007 through 2017, cancer death rates decreased 15% overall, ranging from -4% (rural) to -22% (metropolitan). Targets for breast and colorectal cancer screening were not yet met overall or in any sociodemographic groups except those with the highest educational attainment, whereas lung cancer screening was generally low (<10%). Targets were not yet met overall for cigarette smoking, recent smoking cessation, excessive alcohol use, or obesity but were met for secondhand smoke exposure and physical activity. Some sociodemographic groups did not meet targets or had less improvement than others toward reaching objectives. Monitoring trends in cancer risk factors, screening test use, and mortality can help assess the progress made toward decreasing the cancer burden in the United States. Although many interventions to reduce cancer risk factors and promote healthy behaviors are proven to work, they may not be equitably applied or work well in every community. Implementing cancer prevention and control interventions that are sustainable, focused, and culturally appropriate may boost success in communities with the greatest need, ensuring that all Americans can access a path to long, healthy, cancer-free lives.
Sections du résumé
BACKGROUND
The Centers for Disease Control and Prevention, the American Cancer Society, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States and to address a special topic of interest. Part I of this report focuses on national cancer statistics, and part 2 characterizes progress in achieving select Healthy People 2020 cancer objectives.
METHODS
For this report, the authors selected objectives-including death rates, cancer screening, and major risk factors-related to 4 common cancers (lung, colorectal, female breast, and prostate). Baseline values, recent values, and the percentage change from baseline to recent values were examined overall and by select sociodemographic characteristics. Data from national surveillance systems were obtained from the Healthy People 2020 website.
RESULTS
Targets for death rates were met overall and in most sociodemographic groups, but not among males, blacks, or individuals in rural areas, although these groups did experience larger decreases in rates compared with other groups. During 2007 through 2017, cancer death rates decreased 15% overall, ranging from -4% (rural) to -22% (metropolitan). Targets for breast and colorectal cancer screening were not yet met overall or in any sociodemographic groups except those with the highest educational attainment, whereas lung cancer screening was generally low (<10%). Targets were not yet met overall for cigarette smoking, recent smoking cessation, excessive alcohol use, or obesity but were met for secondhand smoke exposure and physical activity. Some sociodemographic groups did not meet targets or had less improvement than others toward reaching objectives.
CONCLUSIONS
Monitoring trends in cancer risk factors, screening test use, and mortality can help assess the progress made toward decreasing the cancer burden in the United States. Although many interventions to reduce cancer risk factors and promote healthy behaviors are proven to work, they may not be equitably applied or work well in every community. Implementing cancer prevention and control interventions that are sustainable, focused, and culturally appropriate may boost success in communities with the greatest need, ensuring that all Americans can access a path to long, healthy, cancer-free lives.
Identifiants
pubmed: 32162329
doi: 10.1002/cncr.32801
pmc: PMC7223723
mid: NIHMS1570823
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2250-2266Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
© 2020 American Cancer Society.
Références
Prev Med Rep. 2018 May 22;11:93-99
pubmed: 29984145
JAMA. 2014 Jun 25;311(24):2475-6
pubmed: 24870206
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
J Thorac Oncol. 2016 Nov;11(11):1856-1862
pubmed: 27346412
Nicotine Tob Res. 2014 Oct;16(10):1307-18
pubmed: 24812025
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
CA Cancer J Clin. 2019 May;69(3):184-210
pubmed: 30875085
J Natl Cancer Inst. 2013 Aug 7;105(15):1096-110
pubmed: 23878350
J Cancer Educ. 2017 Mar;32(1):125-134
pubmed: 26411308
Tob Control. 2015 Nov;24(6):568-73
pubmed: 25015370
Gastroenterology. 2008 May;134(5):1570-95
pubmed: 18384785
J Natl Cancer Inst. 2019 Dec 1;111(12):1279-1297
pubmed: 31145458
Ann Intern Med. 2015 Oct 20;163(8):622-34
pubmed: 26389730
J Natl Cancer Inst. 1990 May 16;82(10):825-35
pubmed: 2332901
Ann Intern Med. 2014 Mar 4;160(5):330-8
pubmed: 24378917
Front Public Health. 2018 Aug 31;6:219
pubmed: 30234082
Cancer. 2007 Nov 15;110(10):2119-52
pubmed: 17939129
J Clin Oncol. 2015 May 20;33(15):1631-2
pubmed: 25897157
Am J Prev Med. 2019 Nov;57(5):645-651
pubmed: 31443954
Medicine (Baltimore). 2017 Dec;96(50):e9125
pubmed: 29390313
N Engl J Med. 2017 Aug 31;377(9):849-861
pubmed: 28854088
J Womens Health (Larchmt). 2019 Apr;28(4):427-431
pubmed: 30969905
Prev Med Rep. 2018 Mar 24;10:200-203
pubmed: 29868368
Am J Prev Med. 2016 May;50(5):e123-e131
pubmed: 26699245
Prev Med. 2016 Dec;93:96-105
pubmed: 27687535
J Community Health. 2016 Oct;41(5):1013-20
pubmed: 26994988
Am J Public Health. 2012 Nov;102(11):2173-80
pubmed: 22994180
Cancer Causes Control. 2015 Dec;26(12):1709-18
pubmed: 26358830
Nicotine Tob Res. 2018 Sep 25;20(11):1327-1335
pubmed: 29059420
J Gen Intern Med. 2012 Aug;27(8):1068-78
pubmed: 22798216
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
pubmed: 15285078
SM J Community Med. 2017;3(1):
pubmed: 29629435
J Natl Med Assoc. 2016 Winter;108(4):211-219
pubmed: 27979006
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
MMWR Morb Mortal Wkly Rep. 2018 Apr 06;67(13):390-395
pubmed: 29621205
Prev Chronic Dis. 2014 Feb 27;11:E29
pubmed: 24576396
PLoS One. 2014 Apr 15;9(4):e94670
pubmed: 24736389
MMWR Morb Mortal Wkly Rep. 2017 Oct 03;66(39):1052-1058
pubmed: 28981482
BMC Public Health. 2018 Jun 14;18(1):736
pubmed: 29902978
MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):313-319
pubmed: 28358798
N Engl J Med. 2019 Feb 7;380(6):512-515
pubmed: 30601710
Alcohol Clin Exp Res. 2011 Sep;35(9):1557-60
pubmed: 21599711
J Hum Behav Soc Environ. 2014 Mar;24(3):399-407
pubmed: 25580074
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
CA Cancer J Clin. 2002 May-Jun;52(3):134-49
pubmed: 12018928
Cancer. 2012 May 1;118(9):2338-66
pubmed: 22460733
Nicotine Tob Res. 2015 Aug;17(8):892-7
pubmed: 25516538
Am J Prev Med. 2019 Apr;56(4):548-562
pubmed: 30772152
JAMA Intern Med. 2017 Mar 1;177(3):399-406
pubmed: 28135352
MMWR Morb Mortal Wkly Rep. 2018 Dec 07;67(48):1342-1346
pubmed: 30521502
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Am J Public Health. 2015 Jun;105(6):1120-7
pubmed: 25905846
Cancer. 2015 Jul 1;121(13):2281-5
pubmed: 25763558
Ann Intern Med. 2012 Jul 17;157(2):120-34
pubmed: 22801674
JAMA. 2016 Jun 21;315(23):2564-2575
pubmed: 27304597
Addiction. 2015 Jan;110(1):59-68
pubmed: 25138287
MMWR Morb Mortal Wkly Rep. 2017 Mar 03;66(8):201-206
pubmed: 28253225
MMWR Morb Mortal Wkly Rep. 2018 Nov 09;67(44):1225-1232
pubmed: 30408019
Nicotine Tob Res. 2019 Apr 17;21(5):576-583
pubmed: 30496491
JAMA. 2018 Jan 9;319(2):154-164
pubmed: 29318276
Prostate Cancer Prostatic Dis. 2017 Mar;20(1):72-78
pubmed: 27698439
Lancet Public Health. 2019 Mar;4(3):e137-e147
pubmed: 30733056
Cancer. 2018 Jul 1;124(13):2801-2814
pubmed: 29786851
JAMA. 2018 Aug 21;320(7):674-686
pubmed: 30140884
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1563-1579
pubmed: 31575553
Prev Chronic Dis. 2015 Jul 02;12:E104
pubmed: 26133647
MMWR Recomm Rep. 2009 Jul 24;58(RR-7):1-26
pubmed: 19629029
Ann Oncol. 2014 Oct;25(10):1901-14
pubmed: 24769692